SGYP

Synergy Pharma

Synergy Pharma (SGYP)

NASDAQ
3.770.16 (4.07%)Updating Price
Delay +15 min
Stock ratings and Insider transaction returns are measured over a
period with
benchmark.
Learn how to set expert rankings:
Investment time frame (1 Year)
TipRanks measures the stock performance over a one-year time period. For Corporate Insiders, this period is measured starting from the transaction date. You can see how well experts have performed on longer, or shorter, time periods by setting this parameter. Now you can conclude if you are taking advice from the right expert.
Benchmark comparison (No Benchmark)
TipRanks allows you to compare each recommendation, or Corporate Insider transaction to the performance of the S&P 500, or to the sector of the company, to determine if the Expert, or Insider outperforms the market or not.
Reset to default Settings
Details

Analysts Covering Synergy PharmaAnalyst Ratings

Showing:

Analyst Consensus

Moderate Buy

Based on 4 Analyst Ratings


  • 3 Buy
  • 0 Hold
  • 1 Sell

Based on 4 Wall Street analysts offering recommendations for SGYP in the last 3 months (by analysts ranked 0 to 5 stars).

Analyst Price Target on SGYP

Average Price Target

$13.33

(253.58% Upside)

Based on 4 analysts offering 12 month price targets for SGYP in the last 3 months. The average price target is $13.33 with a high estimate of $18.00 and a low estimate of $9.00.

Filters

Position

Action

Ranking

UpgradeUpgrade to see the 5 most recent recommendations
Analyst Ratings
Article
H.C. Wainwright
0.1 out of 5
H.C. Wainwright
0.1 out of 5
Buy
$18.00
$18.00
Reiterated
No article available
Canaccord Genuity
0.1 out of 5
Canaccord Genuity
0.1 out of 5
Buy
$13.00
$13.00
Reiterated
Oppenheimer
0.3 out of 5
Oppenheimer
0.3 out of 5
Buy
$9.00
$9.00
Reiterated
Citigroup
3.8 out of 5
Citigroup
3.8 out of 5
Sell
-
-
Downgraded
Roth Capital
0.1 out of 5
Roth Capital
0.1 out of 5
Buy
$10.50
$10.50
Reiterated
BTIG
4.4 out of 5
BTIG
4.4 out of 5
Buy
$11.00
$11.00
Reiterated

See the highest rated stocks in the Healthcare sector

Rate Gauge

Blogger Opinions on Synergy Pharma

Blogger Consensus

Bullish: 92%
Sector
Average
Bullish
SGYP Blogger consensus is based on 14 Blogger Opinions, the Blogger consensus is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

  • 71% seekingalpha.com
  • 14% investorplace.com
  • 7% misc.com
  • 8% Others
Article
Distribution

Top Blogger Bearish Opinions

Not enough top blogger opinions at this time.
VS

Top Blogger Bullish Opinions

Filter Opinions

Blogger Opinions

Ranking

UpgradeUpgrade to see the 5 most recent opinions
Blogger Opinions
Article
Seeking Alpha
1.2243021895370214 out of 5
Seeking Alpha
Bullish
Bullish
TheStreet.com
0.12284806953033578 out of 5
TheStreet.com
Bullish
Bullish
Seeking Alpha
1.4357345813137223 out of 5
Seeking Alpha
Bullish
Bullish
Seeking Alpha
4.868794918936988 out of 5
Seeking Alpha
Bullish
Bullish
2.6784221962226304 out of 5
Seeking Alpha
Bullish
Bullish
Seeking Alpha
4.942336620424536 out of 5
Seeking Alpha
Bullish
Bullish
Seeking Alpha
1.0254053150593345 out of 5
Seeking Alpha
Bullish
Bullish
Motley Fool
0.18468995487213757 out of 5
Motley Fool
Bullish
Bullish
Seeking Alpha
1.350493063680428 out of 5
Seeking Alpha
Bullish
Bullish
See the 5 highest rated stocks by financial bloggers in this sectorSee highest rated stocks by financial bloggers in this sectorSee highest rated stocks by financial bloggers in this sector
BULLISH
BEARISH

Corporate Insider Activity on Synergy Pharma

Trend: No Trend Detected

SGYP Insider Transactions

The data in the graph is based on publicly available reports of insider transactions as reported to the SEC.

Insider Confidence Signal

Premium Bannerlock

Upgrade to see Insider confidence signal

Currently not enough data available to determine Insider Confidence Signal

Please return soon as the page is updated accordingly.

Filters

Position

Action

Ranking

UpgradeUpgrade to see the 5 most recent transactions
Corporate Insider Transactions
SEC
Paulson & Co Inc
>10% Owner
1.5 out of 5
>10% Owner
1.5 out of 5
Informative Sell
$593,600
$593,600
Read SEC form
Paulson & Co Inc
>10% Owner
1.5 out of 5
>10% Owner
1.5 out of 5
Informative Sell
$308,784
$308,784
Read SEC form
John Brancaccio
Director
3.2 out of 5
Director
3.2 out of 5
Informative Sell
$14,504
$14,504
Read SEC form
Paulson & Co Inc
>10% Owner
1.5 out of 5
>10% Owner
1.5 out of 5
Informative Sell
$19,487,530
$19,487,530
Read SEC form

News Sentiment on Synergy Pharma

Media Buzz in the last 7 days

0
SGYP This
Week
--
This Week:
0 articles
Weekly Average:
0.0 articles

News Sentiment in the last 7 days

Premium Bannerlock

Unlock to see News Sentiment
for SGYP

SGYP This
Week
Sector
Weekly Average
SGYP:
-- Bullish
-- Bearish
Sector Average:
66% Bullish
34% Bearish

News Score

Premium Bannerlock

Upgrade to see the News Score
for SGYP

Not enough data to generate a news score.

Please return soon as the page is updated accordingly.

Showing:

Media Coverage Analysis

Keywords mentioned in last week’s articles

  • 12-month average price
  • last 3 months
  • includes one commercial
  • irritable bowel syndrome
  • Synergy Pharma reports 1Q loss
  • the stock is currently trading

See 5 similar stocks with higher news sentiment

Hedge Funds Activity on Synergy Pharma

Trend: Hedge Funds Increased Holdings by 277.7K Shares Last Quarter.

Hedge Fund Holdings in SGYP

Based on 203 Hedge Funds covered by TipRanks.

Hedge Fund Confidence Signal

Premium Bannerlock

Upgrade to see Hedge
Fund Confidence Signal

Neutral

Based on activity of 9 Hedge Funds in the recent quarter

SoldBought

Filter Activity

Show Actions

Ranking

Hedge Fund Activity
Moore Capital Management LP
1.8226600985221675 out of 5
New
+100.00%
$1.05M
+100.00%
$1.05M0.03%
Perceptive Advisors LLC
1.6256157635467983 out of 5
Added
+99.49%
$4.56M
+99.49%
$4.56M0.26%
Highbridge Capital Management LLC
1.2068965517241381 out of 5
Added
+19.81%
$289.41K
+19.81%
$289.41K0.00%
Paulson & Co Inc
0.41871921182266014 out of 5
No Change
0.00%
$112.25M
0.00%
$112.25M1.49%
Bruce & Co., Inc.
3.793103448275862 out of 5
No Change
0.00%
$11.65M
0.00%
$11.65M2.79%
Ellington Management Group LLC
1.6995073891625618 out of 5
Reduced
-42.49%
$51.73K
-42.49%
$51.73K0.00%
Driehaus Capital Management LLC
0.566502463054187 out of 5
Reduced
-96.36%
$57.05K
-96.36%
$57.05K0.00%
HBK Investments LP
Not Ranked
Sold Out
-100.00%
-
-100.00%
-0.00%
DAFNA Capital Management, LLC
0.22167487684729037 out of 5
Sold Out
-100.00%
-
-100.00%
-0.00%

Similar Stocks to Synergy Pharma

Company
Price
Market Cap
Sector
Analyst Consensus
Analyst Price Target
SCMP
Sucampo Pharmaceuticals
$10.500.15 (-1.41%)
$456.27M
Healthcare
Strong Buy
$18.63
(77.43% Upside)
IRWD
Ironwood Pharma
$18.310.31 (1.72%)
$2.72B
Healthcare
Strong Buy
$21.00
(14.69% Upside)
NKTR
Nektar Therapeutics
$19.750.47 (2.44%)
$3.06B
Healthcare
Strong Buy
$26.25
(32.91% Upside)
PGNX
Progenics
$6.870.08 (-1.15%)
$482.45M
Healthcare
Moderate Buy
$13.00
(89.23% Upside)
SYN
Synthetic Biologics Inc
$0.630.09 (16.44%)
$74.28M
Healthcare
Moderate Buy